Hematology NewsSOX11 shows value as diagnostic marker in MCLDecember 4, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsAcalabrutinib may outperform other targeted therapies in MCLDecember 4, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsASH preview: Key themes include tackling CAR T obstacles, sickle cell advances, VTENovember 26, 2019Cellular TherapyALLMultiple MyelomaLymphoma & Plasma Cell DisordersImmuno-oncologyImmunotherapy
Hematology NewsEarly lenalidomide may delay progression of smoldering myelomaNovember 19, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsRituximab maintenance has a durable benefit in follicular lymphomaNovember 19, 2019Follicular LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsCAR T-cell ‘cocktail’ may overcome antigen escape relapseNovember 18, 2019B Cell LymphomaImmunotherapyLymphoma & Plasma Cell DisordersALLCellular Therapy
Hematology NewsAdding polatuzumab extends survival in relapsed/refractory DLBCLNovember 16, 2019B Cell LymphomaDLBCLLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves Brukinsa for relapsed, refractory MCLNovember 15, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsGene signature may help guide initial CLL treatment choiceNovember 14, 2019CLLB Cell LymphomaLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Hematology NewsFoundation launches direct-to-patient registry in multiple myelomaNovember 13, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersPatient & Survivor Care
Hematology NewsArmored CAR T cells elicit responses in NHL patientsNovember 12, 2019B Cell LymphomaDLBCLLymphoma & Plasma Cell DisordersFollicular LymphomaImmunotherapyCellular TherapyImmuno-oncology
Hematology NewsSurvival ‘excellent’ after rituximab-bendamustine induction in transplant-eligible MCLNovember 6, 2019Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsLevofloxacin prophylaxis improves survival in newly diagnosed myelomaNovember 1, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsConsider renal function in TLS risk assessment of venetoclax-treated CLLOctober 29, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeFDA proposes new breast implant labeling with a boxed warningOctober 24, 2019Patient & Survivor CareLymphoma & Plasma Cell Disorders
